Mouse Anti-MAP3K14 (AA 769-947) Recombinant Antibody (CBFYM-1514) (CBMAB-M1677-FY)

Name: Mouse Anti-MAP3K14 (AA 769-947) Recombinant Antibody (CBFYM-1514)
SKU: CBMAB-M1677-FY
Rating: 5 (1 reviews)

See all MAP3K14 antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

CBFYM-1514

Application

ELISA, IHC

Immunogen

Recombinant corresponding to AA 769-947 from human NIK expressed in E.coli.Immunogen type: Recombinant protein

Specificity

Human

Antibody Isotype

IgG2a

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Lyophilized

Concentration

0.5 mg/mL

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Epitope

AA 769-947

More Infomation

Target

Full Name

MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14

Introduction

This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor family and to the interleukin-1 type-I receptor.

Entrez Gene ID

9020

UniProt ID

Q99558

Alternative Names

Mitogen-Activated Protein Kinase Kinase Kinase 14; Serine/Threonine-Protein Kinase NIK; NF-Kappa-Beta-Inducing Kinase; HSNIK; NIK; Serine/Threonine Protein-Kinase; EC 2.7.11.25; FTDCR1B; HS

Function

Lymphotoxin beta-activated kinase which seems to be exclusively involved in the activation of NF-kappa-B and its transcriptional activity. Promotes proteolytic processing of NFKB2/P100, which leads to activation of NF-kappa-B via the non-canonical pathway. Could act in a receptor-selective manner.

Biological Process

Cellular response to mechanical stimulusManual Assertion Based On ExperimentIEP:UniProtKB
Defense response to virusManual Assertion Based On ExperimentIDA:UniProtKB
I-kappaB kinase/NF-kappaB signalingISS:UniProtKB
Immune responseISS:UniProtKB
NIK/NF-kappaB signalingTAS:Reactome
Positive regulation of I-kappaB kinase/NF-kappaB signalingManual Assertion Based On ExperimentIMP:UniProtKB

Cellular Location

Cytoplasm

PTM

Autophosphorylated. Phosphorylation at Thr-559 is required to activates its kinase activity and 'Lys-63'-linked polyubiquitination. Phosphorylated by CHUK/IKKA leading to MAP3K14 destabilization.
Ubiquitinated. Undergoes both 'Lys-48'- and 'Lys-63'-linked polyubiquitination. 'Lys-48'-linked polyubiquitination leads to its degradation by the proteasome, while 'Lys-63'-linked polyubiquitination stabilizes and activates it.

Hong, Y., Heo, J., Kang, S., Vu, T. H., Lillehoj, H. S., & Hong, Y. H. (2023). Exosome-mediated delivery of gga-miR-20a-5p regulates immune response of chicken macrophages by targeting IFNGR2, MAPK1, MAP3K5, and MAP3K14. Animal Bioscience, 36(6), 851.

Cormier, F., Housni, S., Dumont, F., Villard, M., Cochand-Priollet, B., Mercier-Nomé, F., ... & Groussin, L. (2023). NF-κB signaling activation and roles in thyroid cancers: implication of MAP3K14/NIK. Oncogenesis, 12(1), 55.

Zhang, J., He, L., Li, Q., Gao, J., Zhang, E., & Feng, H. (2023). EGR1 knockdown confers protection against ferroptosis and ameliorates intervertebral disc cartilage degeneration by inactivating the MAP3K14/NF-κB axis. Genomics, 115(5), 110683.

Huang, Q., Liu, Y., Qiu, M., Lin, Q., Wei, X., Zhou, Z., ... & Yu, H. (2022). Potentially functional variants of MAP3K14 in the NF-κB signaling pathway genes predict survival of HBV-related hepatocellular carcinoma patients. Frontiers in Oncology, 12, 990160.

Vesting, A. J., Jais, A., Klemm, P., Steuernagel, L., Wienand, P., Fog-Tonnesen, M., ... & Wunderlich, F. T. (2022). NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibition. Molecular Metabolism, 66, 101626.

Hamdan, T. A., Bhat, H., Cham, L. B., Adomati, T., Lang, J., Li, F., ... & Lang, K. S. (2020). Map3k14 as a regulator of innate and adaptive immune response during acute viral infection. Pathogens, 9(2), 96.

Lian, Y., Hu, Y., Gan, L., Huo, Y. N., Luo, H. Y., & Wang, X. Z. (2019). Ssc-novel-miR-106-5p reduces lipopolysaccharide-induced inflammatory response in porcine endometrial epithelial cells by inhibiting the expression of the target gene mitogen-activated protein kinase kinase kinase 14 (MAP3K14). Reproduction, Fertility and Development, 31(10), 1616-1627.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-MAP3K14 (AA 769-947) Recombinant Antibody (CBFYM-1514)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-MAP3K14 Recombinant Antibody (CBT4290) (CAT#: V2LY-0625-LY1243)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry